Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32325490

Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2020 Aug 20
First author
Voorhees PM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2020 Aug 20;136(8):917-918. doi: 10.1182/blood.2020006298.
    note
    Source null
    related pmid
    32818244
    relationship
    Comment in

Authors and identifiers

  1. name
    Voorhees PM
    type
    Author
  2. name
    Kaufman JL
    type
    Author
  3. name
    Laubach J
    type
    Author
  4. name
    Sborov DW
    type
    Author
  5. name
    Reeves B
    type
    Author
  6. name
    Rodriguez C
    type
    Author
  7. name
    Chari A
    type
    Author
  8. name
    Silbermann R
    type
    Author
  9. name
    Costa LJ
    type
    Author
  10. name
    Anderson LD Jr
    type
    Author
  11. name
    Nathwani N
    type
    Author
  12. name
    Shah N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Voorhees PM
    type
    Author
  2. name
    Kaufman JL
    type
    Author
  3. name
    Laubach J
    type
    Author
  4. name
    Sborov DW
    type
    Author
  5. name
    Reeves B
    type
    Author
  6. name
    Rodriguez C
    type
    Author
  7. name
    Chari A
    type
    Author
  8. name
    Silbermann R
    type
    Author
  9. name
    Costa LJ
    type
    Author
  10. name
    Anderson LD Jr
    type
    Author
  11. name
    Nathwani N
    type
    Author
  12. name
    Shah N
    type
    Author
bibliography ids
  1. nci-bib-ea203a46748d60dfa102a2c1
book metadata
content sha256
caf6e286b4422b91a9c2a45dfe28e25cb48c9271e0c502f1cea13cb5a8d26db0
document type
citation
dois
  1. 10.1182/blood.2020005288
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:32325490
immutable id
pubmed:32325490@caf6e286b4422b91a9c2a45dfe28e25cb48c9271e0c502f1cea13cb5a8d26db0
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
8
name
Blood
nlm unique id
7603509
pages
936-945
volume
136
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2020 Aug 20;136(8):917-918. doi: 10.1182/blood.2020006298.
    note
    Source null
    related pmid
    32818244
    relationship
    Comment in
outcomes validated
false
pmid
32325490
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
fcbb92dce0bc02ff2e15b2c47c9e6375f39c249550f791b6cab842ba63cecc40
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Aug 20
precision
day
year
2020
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32325490/
title
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

Preserved source evidence · Not medical advice